The world’s second largest producer of monoclonal antibodies in immuno-hematology has been awarded €6.5 million from the French state as part of the France 2030 Plan.
The French specialist in immuno-hematology diagnostic solutions aims to implement its “Diagast Origins” project to participate in the joint effort to guarantee France’s national health sovereignty. This aim, which was laid out as early as June 2021 by French President Emmanuel Macron, necessarily includes transfusion safety.
Read more in the pdf file below.
Article from https://frenchhealthcare.fr/
